Trial Profile
Prospective Randomized Trial of Immediate Treatment with Campath versus Deferred Therapy in Patients with Previously Untreated Binet Stage A B-Cell Chronic Lymphocytic Leukemia at High Risk for Disease Progression.
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 22 Jul 2011
Price :
$35
*
At a glance
- Drugs Alemtuzumab (Primary)
- Indications Chronic lymphocytic leukaemia
- Focus Therapeutic Use
- 22 Jul 2011 New trial record